The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpirax-Sarco Regulatory News (SPX)

Share Price Information for Spirax-Sarco (SPX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 8,785.00
Bid: 8,780.00
Ask: 8,790.00
Change: 0.00 (0.00%)
Spread: 10.00 (0.114%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 8,785.00
SPX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Statement - Trading Update

15 May 2018 07:00

RNS Number : 0291O
Spirax-Sarco Engineering PLC
15 May 2018
 

 

 

News Release

 

Tuesday 15th May 2018

AGM Statement - TRADING UPDATE

Overall expectations unchanged, acquisitions continue to perform in line with plan

 

Spirax-Sarco Engineering plc, the world leader in the control and efficient use of steam, electrical thermal energy solutions and peristaltic pumping and associated fluid path technologies, issues the following trading update in respect of the period ended 30th April 2018.

 

Economic environment

The global macro-economic environment for the Group remains positive with global Industrial Production (IP) growth for 2018 forecast to be very similar to that achieved in 2017.

 

Trading

In line with the macro-economic environment and as anticipated at the time of our preliminary announcement in March, organic* sales growth for the Group in the first four months of the year has been very similar to the first four months of 2017 for both the Steam Specialties and Watson-Marlow businesses. Within the Steam Specialties business we have seen improved growth in the Americas, while growth has been lower in Asia Pacific and EMEA, albeit both segments had a very strong start to the year in 2017. Watson-Marlow continues to see growth in EMEA, Asia Pacific and the Americas.

 

The integration of the two acquisitions made in 2017, Gestra which was acquired in May and Chromalox which joined the Group in July, is progressing to schedule and the businesses continue to perform in line with their respective acquisition plans.

 

As expected, the currency tailwind that we experienced in the last two years has become a headwind in the current year. Since the announcement of our preliminary results in March, sterling has strengthened slightly against the basket of currencies we trade in. If April's foreign exchange rates were to continue for the rest of the year we would expect to see a reduction in sales and profits due to currency movements of 3% and 5% respectively. Movements in exchange rates are often volatile and unpredictable, therefore the actual impact could be significantly different.

 

On an organic, constant currency basis, Group operating profit is ahead of the comparable four-month period in 2017 and we continue to prioritise investments for growth over further margin expansion.

 

 

Financial position

Our business remains highly cash generative and we maintain a strong balance sheet. At 30th April 2018 net debt was £345 million. There has been no material change in the financial position of the Group during the period.

 

 

Outlook

We have good diversification across market sectors and geographic regions, and remain focused on the rigorous implementation of our strategies for growth. While, as normal, our short order book continues to provide only limited visibility, the Group's fundamental strengths stand us in good stead to continue to deliver growth that outperforms our markets.

 

Organic sales growth in the first four months has been very much as anticipated and is consistent with that experienced in the same period in the prior year. With forecasts for Industrial Production growth rates for 2018 also similar to those seen in 2017 our overall expectations of organic growth and trading margins for the full-year are unchanged to those set out in our preliminary announcement in March. Provided there is no material deterioration in trading conditions the Board has confidence that the Group will make further progress in 2018.

 

Spirax-Sarco Engineering plc expects to publish its 2018 half-year results on Wednesday 8th August 2018.

 

Enquiries:

Nicholas Anderson, Chief Executive

Kevin Boyd, Group Finance Director

Tel: 01242 535234

 

 

* References to organic changes are excluding acquisitions and disposals, and are expressed at constant currency.

References to profit are to adjusted profit that excludes the amortisation and impairment of acquisition-related intangible assets and acquisition and disposal costs, together with the tax effects of these items.

 

About SpiraxSarco Engineering plc

SpiraxSarco Engineering plc comprises two worldleading businesses, Spirax Sarco for steam and electrical thermal energy solutions and WatsonMarlow Fluid Technology Group for niche peristaltic pumps and associated fluid path technologies.  Spirax Sarco provides a broad range of fluid control and electrical process heating products, engineered packages, site services and systems expertise for a diverse range of industrial and institutional customers. The business helps its end users to improve production efficiency, reduce energy costs, water usage and emissions, improve product quality and enhance the safety of their operations. WatsonMarlow Fluid Technology Group offers the ideal solution for a wide variety of demanding fluid path applications with highly accurate, controllable and virtually maintenance free pumps and associated technologies.  The Group is headquartered in Cheltenham, England, has strategically located manufacturing plants around the world and employs over 7,250 people, of whom approximately 1,600 are direct sales and service engineers. Its shares have been listed on the London Stock Exchange since 1959 (symbol: SPX).

 

Further information can be found at www.spiraxsarcoengineering.com

 

RNS filter: Inside information prior to release

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMGGUCUAUPRGQC
Date   Source Headline
10th Apr 20244:44 pmRNSDirector/PDMR Shareholding
26th Mar 20249:33 amRNSDirector/PDMR Shareholding
20th Mar 202410:00 amRNSDirector/PDMR Shareholding
18th Mar 20242:34 pmRNSHolding(s) in Company
7th Mar 20247:00 amRNS2023 Full Year Results
22nd Feb 20247:00 amRNSSpirax-Sarco Engineering rebrands as Spirax Group
1st Feb 20243:38 pmRNSChange of Director Details
30th Jan 202411:15 amRNSFuture Board Change
17th Jan 20247:00 amRNSLeadership Succession
18th Dec 20237:00 amRNSChief Financial Officer Appointment
21st Nov 20239:15 amRNSDirector/PDMR Shareholding
20th Nov 20237:00 amRNSDirector/PDMR Shareholding
20th Nov 20237:00 amRNSShare Purchases
16th Nov 20237:00 amRNSTrading Update
11th Oct 20238:40 amRNSDirector/PDMR Shareholding
25th Aug 20239:30 amRNSHolding(s) in Company
25th Aug 20238:30 amRNSHolding(s) in Company
10th Aug 20237:00 amRNS2023 Half Year Results
8th Aug 20237:00 amRNSGroup Chief Executive Succession
2nd Aug 20238:00 amRNSBoard Appointment
1st Aug 20239:09 amRNSDirector/PDMR Shareholding
27th Jul 20239:30 amRNSChange in Director Details
26th Jun 202310:00 amRNSNotice of Investment Seminar
22nd Jun 20232:03 pmRNSHolding(s) in Company
22nd Jun 20237:00 amRNSKyoto Investment and Partnership Agreement
14th Jun 202310:42 amRNSHolding(s) in Company
9th Jun 20235:45 pmRNSHolding(s) in Company
24th May 20232:46 pmRNSHolding(s) in Company
10th May 20233:23 pmRNSResult of AGM
10th May 20237:00 amRNSAGM Trading Update
16th Mar 20234:22 pmRNSDirector/PDMR Shareholding
16th Mar 20239:00 amRNSDirector/PDMR Shareholding
15th Mar 20234:12 pmRNSDirector/PDMR Shareholding
15th Mar 20239:53 amRNSDirector/PDMR Shareholding
15th Mar 20239:48 amRNSHolding(s) in Company
13th Mar 20231:31 pmRNSDirector/PDMR Shareholding
13th Mar 202312:22 pmRNSDirector/PDMR Shareholding
9th Mar 20237:00 amRNS2022 Full Year Results
8th Mar 20233:09 pmRNSChange of Director Details
21st Feb 202310:32 amRNSHolding(s) in Company
31st Jan 20239:30 amRNSBoard Changes
30th Jan 20236:04 pmRNSHolding(s) in Company
23rd Dec 202210:31 amRNSDirector/PDMR Shareholding
1st Dec 20227:00 amRNSCompletion of the Acquisition of Durex Industries
17th Nov 20227:00 amRNSTrading Statement
27th Oct 20224:24 pmRNSDirector/PDMR Shareholding
4th Oct 20227:00 amRNSDirector/PDMR Shareholding
30th Sep 20227:00 amRNSCompletion of the acquisition of Vulcanic
28th Sep 20227:00 amRNSAcquisition of US Thermal Energy Specialist
6th Sep 202212:41 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.